3136 results for «2877»

Filter By

3136 results

EuroPCR 2022 Hotlines / Late-Breaking Trials in hypertension management: SPYRAL-HTN ON MED, radiance HTN SOLO and TRIO, and more!

17 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in hypertension management! Blood pressure and MACE reductions after renal denervation: 3-year GSR results, patient-level pooled analysis of ultrasound RDN in radiance-HTN SOLO and Trio, and SPYRAL-HTN ON MED 3 year data.

EuroPCR 2022 Hotlines / Late-Breaking Trials in hypertension management: SPYRAL-HTN ON MED, radiance HTN SOLO and TRIO, and more!

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary artery disease: MASTER DAPT, CRUZ-HBR, DISCO RADIAL, and more!

17 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in coronary artery disease! Abbreviated DAPT after complex PCI in high bleeding risk patients, comparing conventional and haemostatic dressings in radial access, angio-based QFR virtual PCI vs. conventional angio-guided PCI, CRUZ-HBR, CT-guided invasive coronary angiography in patients with...

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary artery disease: MASTER DAPT, CRUZ-HBR, DISCO RADIAL, and more!

Advancing structural heart with 3D ICE and device guidance

17 Nov 2025 – From PCR London Valves 2025

This PCR London Valves 2025 session explores how 3D TEE, 3D intracardiac echocardiography (ICE), and DeviceGuide technology sharpen procedural accuracy, strengthen operator confidence, and streamline decision-making in real time.

You’ll see how clearly defined team roles enhance both safety and efficiency, and how thoughtful workflow integration can reduce...

Advancing structural heart with 3D ICE and device guidance

Align for the future with next gen Myval transcatheter heart valve series

16 Nov 2025 – From PCR London Valves 2025

Discover how the latest Myval transcatheter heart valve (THV) innovations are shaping TAVI outcomes. This PCR London Valves 2025 session highlights the clinical evidence behind the next-gen Myval THV series, best practices for implantation, and upcoming innovations set to improve patient care. Learn step-by-step techniques for deploying Myval...

Align for the future with next gen Myval transcatheter heart valve series

Cardiovalve hits the TARGET: advancing transcatheter valve replacement

18 Nov 2025 – From PCR London Valves 2025

This session highlights the features and procedural steps of the next-generation Cardiovalve systems for tricuspid and mitral valve replacement. It reviews interim results from the TARGET study, emphasizing echocardiographic findings and reverse remodeling effects, and discusses best practices for patient selection and the learning pathway to...

Cardiovalve hits the TARGET: advancing transcatheter valve replacement

Cracking the tricuspid code "the Bicaval revolution"

16 Nov 2025 – From PCR London Valves 2025

This session decodes the advancement of caval valve therapy with the TricValve system, offering novel solutions for tricuspid regurgitation and right heart failure. It incorporates insights from clinical trials, real-world cases, and guideline integration, detailing imaging techniques and strategies for complex patient management including rescue interventions.

Cracking the tricuspid code 'the Bicaval revolution'

Day case TAVI - The future standard of care for most TAVI patients

16 Nov 2025 – From PCR London Valves 2025

Examining the UK experience, this session discusses the emerging standard of day case TAVI and its potential application across Europe. It evaluates patient-centered risks and benefits, operational requirements, and the evolving role of clinical valve coordinators to facilitate safe and efficient day case pathways for TAVI...

Day case TAVI - The future standard of care for most TAVI patients

Exceptional engineering, predictable outcomes - Latest development of the VitaFlow TAVI device

17 Nov 2025 – From PCR London Valves 2025

Discover the latest advancements in the VitaFlow transcatheter aortic valve implantation (TAVI) device. This session highlights the electronically enabled VitaFlow Liberty system, delivering consistent immediate and mid-term clinical results. Watch real-world demonstrations of complex cases, including heavily calcified aortas and pure aortic regurgitation, and get a...

Exceptional engineering, predictable outcomes - Latest development of the VitaFlow TAVI device

Hotline - TAVI - Part 1

16 Nov 2025 – From PCR London Valves 2025

This comprehensive session examines the latest evidence and clinical trial data on TAVI, including comparisons of balloon-expandable versus self-expanding valves in failed bioprostheses, techniques to reduce coronary obstruction risk, and real-world outcomes across diverse populations. Cost-effectiveness analyses and longitudinal studies further inform best practices for optimizing...

From innovation to intervention: optimising procedural techniques in tricuspid TEER

17 Nov 2025 – From PCR London Valves 2025

Explore advanced strategies for tricuspid TEER in this PCR London Valves 2025 session.

Through real-world cases and interactive simulation, learn how to optimise outcomes in complex tricuspid anatomy, manage challenges posed by pacemaker leads, and enhance procedural efficiency using the TriClip G5 device.

Gain practical insights on clipping...

From innovation to intervention: optimising procedural techniques in tricuspid TEER

Valve interventions in congenital heart disease

16 Nov 2025 – From PCR London Valves 2025

This session presents complex valve interventions in congenital heart disease, highlighting challenging cases such as positional hypoxaemia due to iatrogenic atrial defects, navigating residual shunts after PFO closure, and transcatheter pulmonary valve replacement in native right ventricular outflow tracts without pre-stenting. It also examines an intriguing...

From repair to replacement: a portfolio of options for your mitral and tricuspid regurgitation patients

16 Nov 2025 – From PCR London Valves 2025

This session explores a full spectrum of therapeutic options for mitral and tricuspid regurgitation, focusing on the PASCAL Precision system for targeted repair and the SAPIEN M3 transcatheter mitral valve replacement. Through beating heart simulators, case discussions, and clinical evidence, participants will understand the versatility and...

From repair to replacement: a portfolio of options for your mitral and tricuspid regurgitation patients

Getting the full potential of the supra-annular valve in a changing landscape

16 Nov 2025 – From PCR London Valves 2025

This session explores the evolving landscape of transcatheter aortic valve implantation (TAVI) with a focus on supra-annular valve technology. It covers techniques for achieving commissural alignment, considerations for small aortic annuli, and advantages in treating bicuspid aortic valve disease, supported by clinical data and illustrative cases.

Getting the full potential of the supra-annular valve in a changing landscape

Breakout session on Simul-Imaging

16 Nov 2025 – From PCR London Valves 2025

This session focuses on the evolution and impact of simul-imaging in interventional cardiology. It reviews historical perspectives on the FIM procedure, the role of simulation in accelerating the learning curve, and innovative approaches to simulation-based training. Additionally, the session highlights cutting-edge imaging innovations from major industry...

Featured research: innovative solutions for mitral valve repair and replacement

16 Nov 2025 – From PCR London Valves 2025

This featured research session offers a comprehensive exploration of mitral valve interventions, encompassing electrosurgical device removal techniques, transcatheter mitral valve replacement (TMVR) outcomes, and transcatheter edge-to-edge repair (TEER) in complex clinical contexts such as heart transplantation and acute valve syndromes. It further examines pulmonary artery systolic...

Featured research: innovative solutions for mitral valve repair and replacement

Hot topics in structural heart: addressing patients' unmet needs with EVOQUE TTVR and SAPIEN THV-in-THV

17 Nov 2025 – From PCR London Valves 2025

This session addresses emerging topics in structural heart disease by examining patient-centered solutions such as EVOQUE transcatheter tricuspid valve replacement (TTVR) and SAPIEN transcatheter heart valve-in-heart valve (THV-in-THV) procedures. It covers the latest data from Europe on redo TAVI, lifetime management strategies beginning with initial prosthesis...

Hot topics in structural heart: addressing patients' unmet needs with EVOQUE TTVR and SAPIEN THV-in-THV

TAVI in aortic regurgitation

16 Nov 2025 – From PCR London Valves 2025

This session addresses the challenges and innovations in transcatheter aortic valve implantation (TAVI) for aortic regurgitation. It covers complex clinical scenarios such as severe regurgitation post-endocarditis, alternative access routes complicated by prosthesis embolisation, and the use of dedicated TAVI devices in non-tricuspid valves. The session also...

How to optimise TAVI outcomes in extreme patient anatomies?

16 Nov 2025 – From PCR London Valves 2025

Explore strategies to optimise TAVI outcomes in patients with extreme anatomies in this PCR London Valves 2025 session.

Through case-based discussions, the session addresses challenges in small annular anatomy, approaches for large annuli, and strategies to ensure optimal lifetime management for younger TAVI patients. Learn practical tips...

How to optimise TAVI outcomes in extreme patient anatomies?

TAVI-in-TAVI

16 Nov 2025 – From PCR London Valves 2025

This session explores the nuanced field of TAVI-in-TAVI procedures, focusing on valve durability considerations between bovine and porcine valves, strategies for redo TAVI post valve-in-valve, and advanced interventions to secure coronary flow such as inter-valvular stenting. It highlights complex anatomical challenges including aberrant coronary origins and...

Just CINCH - Indirect annuloplasty for secondary mitral regurgitation in heart failure patients

16 Nov 2025 – From PCR London Valves 2025

This session provides a detailed review of indirect annuloplasty as an interventional treatment for secondary mitral regurgitation in heart failure patients, with a focus on the landmark EMPOWER trial. Learn about patient selection optimisation, procedural considerations involving the coronary sinus and left circumflex artery, and future...

Just CINCH - Indirect annuloplasty for secondary mitral regurgitation in heart failure patients
Didn’t find what you were looking for?